Related Experiment Video
Updated: Aug 12, 2026

09:56
Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Published on: March 2, 2016
Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit
T Bernstein1, R Brilli, B Jacobs
1Division of Critical Care Medicine, Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
Summary
Bacterial tracheitis in children is becoming less severe, with older patients and fewer requiring intubation. This study suggests a shift towards a less critical condition, with changing common pathogens observed.
Area of Science:
- Pediatric Intensive Care
- Infectious Diseases
- Respiratory Medicine
Background:
- Bacterial tracheitis historically presented as severe upper-airway obstruction in young, toxic children, often requiring intubation.
- Staphylococcus aureus was previously the predominant pathogen, associated with significant morbidity and mortality.
- Recent trends suggest a potential shift in the epidemiology and clinical presentation of bacterial tracheitis.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of children diagnosed with bacterial tracheitis.
- To compare current patient demographics and treatment requirements with historical data.
- To identify changes in causative pathogens for bacterial tracheitis.
Main Methods:
- Retrospective review of medical records for 46 children admitted to the pediatric intensive care unit with bacterial tracheitis over 14 months.
- Analysis of patient age, clinical presentation, need for tracheal intubation, and causative microorganisms.
- Comparison of findings with previously published literature on bacterial tracheitis.
Main Results:
- Children in this cohort were older (mean age 69.3 months) and less toxic than historically reported.
- Tracheal intubation was required in 57% of patients, with younger children being more likely to require intubation.
- Moraxella catarrhalis and influenza A virus were identified as common pathogens, differing from historical data.
Conclusions:
- Bacterial tracheitis appears to be evolving into a less severe condition with a changing epidemiological profile.
- The findings suggest a decreased morbidity associated with bacterial tracheitis in the current patient population.
- Continued surveillance for causative agents and clinical trends in bacterial tracheitis is warranted.
More Related Videos
Related Concept Videos
Trachea
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

